Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2024-12-30 00:00:00 ET · period of report 2024-12-27 · accession 0001628280-24-052573 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-12-30 | 2024-12-27 | SUPN | Khattar Jack A. | Pres, CEO, Dir | F - Tax | $35.59 | -25.2K | 946.2K | -3% | -$898.0K |
| DM | 2024-12-30 | 2024-12-27 | SUPN | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | +52.6K | 960.2K | +6% | $0 |
| DM | 2024-12-30 | 2024-12-27 | SUPN | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | -52.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-27 | F | D | 6,666 | $35.59 | 953,579 | D | — | — | (F2) Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units. |
| 2 | Common | Common Stock | 2024-12-27 | F | D | 18,567 | $35.59 | 946,245 | D | — | — | (F2) Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units. |
| 3 | Common | Common Stock | 2024-12-27 | M | A | 38,640 | $0.00 | 964,812 | D | — | — | (F1) Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2024. |
| 4 | Common | Common Stock | 2024-12-27 | M | A | 14,000 | $0.00 | 960,245 | D | — | — | (F3) Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 23, 2023. |
| 5 | Derivative | Performance Share Unit | 2024-12-27 | M | D | 14,000 | $0.00 | 0 | D | $0.00 · — to — | 14,000 Common Stock | (F5) On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023 and modified on December 12, 2024. |
| 6 | Derivative | Performance Share Unit | 2024-12-27 | M | D | 38,640 | $0.00 | 0 | D | $0.00 · — to — | 38,640 Common Stock | (F4) On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. |